By World Health AI Editorial
2 sourcesHM Treasury set out a package of AI spending on 24 October 2026 that the Chancellor will take into next week's Budget, with three strands aimed at health: a £165m National AI Biosecurity Initiative, an extra £60m for a Sovereign AI procurement scheme covering health and care challenges, and a £15m AI Challenge Prize whose first award goes to firms tackling health problems 1. The trade body techUK put the whole package at more than £600m 1.
What the package contains
The biosecurity initiative splits into £100m for a new AI Biosecurity Lab (AIBL), which will use AI to detect and track biological threats, and £65m for biosurveillance and medical countermeasures against priority pathogens 1. The Cabinet Office describes AIBL as the first organisation anywhere dedicated to AI biosecurity and puts total backing at up to £300m once company commitments are counted 2. Those commitments are:
- OpenAI: £100m in compute and model credits, plus trusted access to its most capable relevant models through its Rosalind Biodefense programme 2.
- Anthropic: up to £100m in model credits, trusted model access and dedicated technical support 2.
- Google DeepMind and London-based Basecamp Research: research partnerships and access to AI science tools and AI-biology models 12.
AIBL will run as an independent non-profit modelled on the AI Security Institute, with a scientific advisory committee still to be named 2. Its first work will focus on earlier detection of emerging biological threats and faster development of vaccines, treatments and other countermeasures 2. It sits in a national initiative alongside the UK Health Security Agency, the Animal and Plant Health Agency and Dstl, and will work with the MHRA on health emergency preparedness and on how AI-designed medicines are regulated 2.
Away from biosecurity, the extra £60m for the Sovereign AI R&D Procurement Scheme is meant to buy solutions to problems across health and care as well as in AI security and assurance 1. The Treasury also cited existing NHS results: AI now helps clinicians read more than 210,000 chest X-rays a month, around a third of the NHS total, which it links to an 11.5% rise in suspected lung cancers flagged within 24 hours, about 400 more patients a month, and a fall in the average wait for follow-up CT from 6.3 to 5.6 days 1.
What it means for the market
For AI suppliers to the NHS and to public health, the two procurement lines are the most direct opening: a £60m R&D purchasing scheme with health and care named as a target, and a £15m prize whose first round is reserved for health 1. The scheme's scope is shared with AI security and assurance, so the health share is not specified 1.
For frontier model developers, the lab sets a template in which commercial providers fund national capability largely in kind, through credits and model access rather than cash 2. The government says it wants AIBL to draw philanthropic as well as public money over time 2. For drug and vaccine developers, the planned work with the MHRA on regulating AI-designed medicines is the point to watch, though no timetable is given 2.
"AIBL is a bold investment in UK resilience," said Gordon Sanghera, founder of Oxford Nanopore Technologies 1.
Caveats
These are announcements ahead of the Budget, not allocations with delivery dates; the release gives no timetable for spending the procurement or prize money and no split of the £65m 1. The chest X-ray figures describe existing deployments rather than new funding 1. The membership of AIBL's scientific advisory committee is to be set out later 2.
References
- Chancellor unveils Britain’s ambitious plan for AI (opens in a new tab) — GOV.UK (HM Treasury)
- Introducing the AI Biosecurity Lab (opens in a new tab) — GOV.UK
This briefing summarises publicly available research and reporting for information only. It is not medical, investment or legal advice. Follow the references to the primary sources.